Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://cr.elmerpub.com

Review

Volume 15, Number 6, December 2024, pages 415-424

A Promising Pathway Toward Mitigation and Eradication of Coronary Artery Disease

Figures

Figure 1.
Figure 1. Summary of the pathway for the eradication of CAD. This general overview begins with identifying individuals with unknown risk, followed by testing coronary CTA and AI-based plaque analysis, combined with genetic profiling using a polygenic risk score (PRS) to assess risk. The next step is personalized therapy, concluding with ongoing follow-up to prevent future events. AI: artificial intelligence; CAD: coronary artery disease; CTA: computed tomographic angiography.
Figure 2.
Figure 2. Summary of multiple contributors to atherosclerosis and CAD, also a simple but comprehensive flowchart is proposed with the use of personalized combination of medications using non-RNA and RNA drugs. CAD: coronary artery disease; RNA: ribonucleic acid.